ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

3 Market-Beating Stocks on Our Buy List

CDNS Cover Image

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.

It’s clear there’s a strong connection between sustained earnings growth and hall-of-fame returns. Keeping that in mind, here are three market-beating stocks with room for further growth.

Cadence (CDNS)

5-Year Return: +281%

With the name chosen to reflect the idea of a repeating pattern or rhythm in electronic design, Cadence Design Systems (NASDAQ: CDNS) offers a software-as-a-service platform for semiconductor engineering and design.

Why Is CDNS a Good Business?

  1. Billings growth has averaged 16.2% over the last year, indicating a healthy pipeline of new contracts that should drive future revenue increases
  2. Superior software functionality and low servicing costs result in a best-in-class gross margin of 86%
  3. Software platform has product-market fit given the rapid recovery of its customer acquisition costs

Cadence is trading at $252.30 per share, or 13.2x forward price-to-sales. Is now the right time to buy? Find out in our full research report, it’s free.

Powell (POWL)

5-Year Return: +440%

Originally a metal-working shop supporting local petrochemical facilities, Powell (NYSE: POWL) has grown from a small Houston manufacturer to a global provider of electrical systems.

Why Will POWL Outperform?

  1. Market share has increased this cycle as its 38.5% annual revenue growth over the last two years was exceptional
  2. Earnings per share grew by 337% annually over the last two years and trumped its peers
  3. Rising returns on capital show management is finding more attractive investment opportunities

Powell’s stock price of $173.20 implies a valuation ratio of 11.8x forward price-to-earnings. Is now a good time to buy? See for yourself in our in-depth research report, it’s free.

HCA Healthcare (HCA)

5-Year Return: +138%

Founded in 1968 as a single hospital, HCA Healthcare (NYSE: HCA) is one of the largest hospital operators in the US today, running hospitals, urgent care centers, surgery centers, and emergency rooms.

Why Is HCA a Top Pick?

  1. Massive revenue base of $70.6 billion in a highly regulated sector makes the company difficult to replace, giving it meaningful negotiating power
  2. Performance over the past five years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
  3. Industry-leading 29.3% return on capital demonstrates management’s skill in finding high-return investments

At $306.05 per share, HCA Healthcare trades at 12.5x forward price-to-earnings. Is now the time to initiate a position? Find out in our full research report, it’s free.

Stocks We Like Even More

The Trump trade may have passed, but rates are still dropping and inflation is still cooling. Opportunities are ripe for those ready to act - and we’re here to help you pick them.

Get started by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years.

Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Sterling Infrastructure (+1,096% five-year return). Find your next big winner with StockStory today for free.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.